Pharmas Look to “Immature” Adult ADHD Market


With the market for juvenile ADHD plateauing at 4.5 million children, pharmaceuticals are looking to the untapped “immature” adult market.  With criteria such as “often fails to give close attention to details”, difficulty in “sustaining attention”, failing to follow through on instructions, difficulty organizing tasks, losing things, being easily distracted, or forgetful, the potential market is estimated to be twice as large as it is in children.

Article →

Previous articleWill the APA Listen to the Voices of Those Harmed by Psychiatric Diagnosis?
Next articleFive Things I Learned at the Partnership with Patients Conference
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].


  1. So… young people who are bored at work because because they are underemployed are a new potential market. When I read about any psychiatrist that is interested/specializes in adult ADHD I know that that person is really just in it for the “market” share.

    Report comment